Eye involvement in rheumatic diseases and antirheumatic therapy
Issue 8/2023 Shumnalieva1, R., Shumnalieva-Ivanova2, V., Kotov1, G., Monov1, S. 1 Clinic of Rheumatology, Department of Rheumatology, UMBAL “St. Ivan…
Biological and targeted therapy for the treatment of psoriasis and psoriatic arthritis
Isse 8/2023 Popova, V. Faculty of Medicine, Rheumatology Clinic, Medical University – Plovdiv; DKZ-1; UMBAL „Kaspela“ – Plovdiv Psoriatic arthritis…
Assessment of the diagnostic features of psoriatic disease in outpatient care
Issue 8/2023 Momcheva1, I. , Hristova2, Sv., Bliznakova2, M., Hristova2, I., Madjova2, V. 1 Department of Rheumatology – Burgas UMHAT…
Why is the diagnosis of inflammatory rheumatological diseases delayed in out-hospital care or can we shange stereotypes?
Issue 8/2023 Kazmin, I., Department of Rheumatology, UMBAL-Burgas On the basis of the available scientific and statistical information, as well…
Etoricoxib – the agent of choice in rheumatology practice
Nestorova, R., Rheumatologist Secretary of the Bulgarian Medical Society for Osteoporosis and Osteoarthritis NSAIDs are the most widely used drugs…
The ANCA associated vasculitides – how to identify them and how they manifest in the Bulgarian population.
Issue 9/2022 T. Yoneva, R. Rashkov, Y. Zdravkova, I. Sheytanov The ANCA associated vasculitides (AAV) are multisystemic autoimmune diseases which…